Kim Dong Yi, Seo Kyeung Won, Joo Jae Kyoon, Park Young Kyu, Ryu Seong Yeob, Kim Hyeong Rok, Kim Young Jin, Kim Shin Kon
Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Medical School, Gwangju, Korea.
World J Gastroenterol. 2006 Feb 28;12(8):1182-6. doi: 10.3748/wjg.v12.i8.1182.
To identify the clinicopathological characteristics of lymph node-negative gastric carcinoma, and also to evaluate outcome indicators in the lymph node-negative patients.
Of 2848 gastric carcinoma patients, 1524 (53.5%) were lymph node-negative. A statistical analysis was performed using the Cox model to estimate outcome indicators.
There was a significant difference in the recurrence rate between lymph node-negative and lymph node-positive patients (14.4% vs 41.0%, P<0.001). The 5-year survival rate was significantly lower in lymph node-positive than in lymph node-negative patients (31.1% vs 77.4%, P<0.001). Univariate analysis revealed that the following factors influenced the 5-year survival rate: patient age, tumor size, depth of invasion, tumor location, operative type, and tumor stage at initial diagnosis. The Cox proportional hazard regression model revealed that tumor size, serosal invasion, and curability were independent, statistically significant, prognostic indicators of lymph node-negative gastric carcinoma.
Lymph node-negative patients have a favorable outcome attributable to high curability, but the patients with relatively large tumors and serosal invasion have a poor prognosis. Curability is one of the most reliable predictors of long-term survival for lymph node-negative gastric carcinoma patients.
明确淋巴结阴性胃癌的临床病理特征,并评估淋巴结阴性患者的预后指标。
在2848例胃癌患者中,1524例(53.5%)为淋巴结阴性。采用Cox模型进行统计分析以评估预后指标。
淋巴结阴性和阳性患者的复发率存在显著差异(14.4%对41.0%,P<0.001)。淋巴结阳性患者的5年生存率显著低于淋巴结阴性患者(31.1%对77.4%,P<0.001)。单因素分析显示,以下因素影响5年生存率:患者年龄、肿瘤大小、浸润深度、肿瘤位置、手术类型及初次诊断时的肿瘤分期。Cox比例风险回归模型显示,肿瘤大小、浆膜侵犯及可治愈性是淋巴结阴性胃癌独立的、具有统计学意义的预后指标。
淋巴结阴性患者因可治愈性高而预后良好,但肿瘤相对较大且有浆膜侵犯的患者预后较差。可治愈性是淋巴结阴性胃癌患者长期生存最可靠的预测指标之一。